FFTY:NYE-Innovator IBD® 50 ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 29.6

Change

-2.36 (-7.38)%

Market Cap

N/A

Volume

0.39M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

-4.54 (-3.36%)

USD 19.16B
VOT Vanguard Mid-Cap Growth Index ..

-7.21 (-2.68%)

USD 16.53B
IJK iShares S&P Mid-Cap 400 Growth..

-2.79 (-3.02%)

USD 9.61B
XMMO Invesco S&P MidCap Momentum ET..

-4.53 (-3.61%)

USD 4.68B
IVOG Vanguard S&P Mid-Cap 400 Growt..

-3.42 (-2.99%)

USD 1.15B
CWS AdvisorShares Focused Equity E..

-0.81 (-1.20%)

USD 0.18B
ETHO Amplify ETF Trust

-1.56 (-2.55%)

USD 0.18B
IPO Renaissance IPO ETF

-1.39 (-3.06%)

USD 0.16B
BFOR Barron's 400 ETF

-1.96 (-2.61%)

USD 0.16B
PEXL Pacer US Export Leaders ETF

-1.15 (-2.26%)

USD 0.05B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.53% 100% F 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.53% 100% F 66% D+
Trailing 12 Months  
Capital Gain 10.41% 56% F 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.41% 56% F 55% F
Trailing 5 Years  
Capital Gain -17.62% 6% D- 30% F
Dividend Return 2.38% 17% F 6% D-
Total Return -15.24% 6% D- 18% F
Average Annual (5 Year Horizon)  
Capital Gain -1.19% 11% F 26% F
Dividend Return -0.50% 11% F 18% F
Total Return 0.69% 61% D- 17% F
Risk Return Profile  
Volatility (Standard Deviation) 30.11% 22% F 35% F
Risk Adjusted Return -1.67% 11% F 20% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.